论文部分内容阅读
血管紧张素转换酶抑制剂 (ＡＣＥＩ)及血管紧张素受体拮抗剂 (ＡＲＢ)的临床应用是近 10年来肾脏病药物治疗中最重要的进展之一。鉴于血管紧张素Ⅱ (ＡｎｇⅡ )在人体的病理生理作用可以归纳为血流动力学与非血流动力学二大类。ＡＣＥＩ与ＡＲＢ的疗效作用也可以区分为血压与非
The clinical application of angiotensin-converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ARB) is one of the most important progresses in the treatment of renal disease in the past 10 years. In view of the role of angiotensin Ⅱ (Ang Ⅱ) in the human body’s pathophysiology can be summarized as two major categories of hemodynamics and non-hemodynamics. The therapeutic effect of ACEI and ARB can also be divided into blood pressure and non-blood